Difference in CD22 molecules in human B cells and basophils-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Difference in CD22 molecules in human B cells and basophils

Published:2002-03 Issue:3 Volume:30 Page:205-211
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Toba Ken,Hanawa Haruo,Fuse Ichiro,Sakaue Minori,Watanabe Kenichi,Uesugi Yumiko,Higuchi Wataru,Takahashi Masuhiro,Aizawa Yoshifusa

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference27 articles.

1. Sialoadhesin and related cellular recognition molecules of the immunoglobulin superfamily;Crocker;Biochem Soc Trans,1996

2. Genomic structure and chromosomal mapping of the human CD22 gene;Wilson;J Immunol,1993

3. cDNA cloning of the B cell membrane protein CD22;Wilson;J Exp Med,1991

4. Activation of B lymphocytes;Doody;Curr Opin Immunol,1996

5. CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-γ1 upon B-cell activation;Law;J Exp Med,1996

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 15‐color highly sensitive flow cytometry assay for post anti‐CD19 targeted therapy (anti‐CD19‐CAR‐T and blinatumomab) measurable residual disease assessment in B‐lymphoblastic leukemia/lymphoma: Real‐world applicability and challenges;European Journal of Haematology;2023-09-14

2. Guidelines for the flow cytometric minimal residual disease monitoring in B-lineage acute lymphoblastic leukemia after CD19-directed immunotherapy;Pediatric Hematology/Oncology and Immunopathology;2023-05-12

3. The International Consensus Classification of Acute Leukemias of Ambiguous Lineage;Blood;2023-03-06

4. Flow cytometric assessment for minimal/measurable residual disease in B lymphoblastic leukemia/lymphoma in the era of immunotherapy;Cytometry Part B: Clinical Cytometry;2023-01-22

5. Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy;Cancers;2022-11-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3